PharmaCielo Ltd.
PCLO.V
TSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 89.43% | 18.84% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 89.43% | 18.84% | |||
| Cost of Revenue | 94.15% | 210.87% | |||
| Gross Profit | 82.00% | -72.15% | |||
| SG&A Expenses | 63.94% | 112.84% | |||
| Depreciation & Amortization | 1,175.44% | 96.55% | |||
| Other Operating Expenses | -105.72% | 208.37% | |||
| Total Operating Expenses | -4.63% | 315.62% | |||
| Operating Income | 53.02% | -188.10% | |||
| Income Before Tax | -8.47% | -419.47% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -8.47% | -419.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -8.47% | -419.47% | |||
| EBIT | 53.02% | -188.10% | |||
| EBITDA | -3.61% | -126.50% | |||
| EPS Basic | 0.00% | -406.25% | |||
| Normalized Basic EPS | -45.45% | -320.00% | |||
| EPS Diluted | 0.00% | -406.25% | |||
| Normalized Diluted EPS | -45.45% | -320.00% | |||
| Average Basic Shares Outstanding | 8.96% | 1.06% | |||
| Average Diluted Shares Outstanding | 8.96% | 1.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||